Innovative solutions to the greatest challenges in pharmaceutical development

9th – 11th March 2020 | Berlin

The perfect mix. The DDF Summit brings together leading formulation development, drug delivery and device development professionals from both industry and academia to share and discuss their latest work.

Quality content. The agenda is packed with carefully selected talks on topics as diverse as the challenges you face.

Invaluable networking. The DDF community is open, friendly and represents and incredibly valuable network of scientists working at the forefront of their field. There is ample networking time built in to help you make and strengthen connections.

Tailor your experience. 4 parallel streams give you the chance to personalise your agenda and delve deep into the topics pertinent to your challenges. Choose from Small Molecules, Biologics, Technology & Innovation or Device Development.

The right size. This year the DDF Summit will be limited to just 500 people, in order to maintain the quality of the networking and comfort for participants. This means that there will only be 250 delegate tickets available. So, don’t waste time in getting yours.

Key themes for 2020 include:

• New modalities research opportunities and challenges
• Personalised therapies, mRNA, Cell and gene therapies
• Analytical techniques for biotherapeutics
• 3D printing, flexible manufacturing techniques, continuous manufacturing
• Multivariate analysis techniques, production process optimisation, digitalisation of
pharmaceutical development
• mAb and bispecific formulation development
• Oral delivery of biologics and other routes
• Device development, microneedles, connected devices
• Integrating human factors into device development, behavioural design

Have a look at our 2020 agenda here or download our brochure

We are now looking for speakers for the 2020 Summit. If you have a case study to share or a speaker to suggest, please contact

Download 2020 Brochure

2020 Speakers

Anand Subramony


Vice President, External Innovation & Novel Technologies

Conference Chairperson

Andreas Abend


Director Analytical Sciences

Andrew Lewis

Quotient Sciences

Vice President, Pharmaceutical Sciences

Anne Moore

University College Cork


Bertil Abrahamsson


Senior Principal Scientist

Birgit Steiner-Zitzenbacher

Fresenius Kabi

Vice President Innovation & Development Centre Europe

Brian K. Meyer


Principal Scientist New Technologies, Vaccine Drug Product Development, Bioprocess Research and Development

Charles Evans


VP of Pharmaceutical Development

Claus-Michael Lehr

Helmholtz Institute for Pharmaceutical Research Saarland

Head of the Department Drug Delivery

Cornelia Kruettli


Section Head Product Care Device and Packaging Development

Daniel Bonner

PureTech Health

Vice President

Davide Mercadante


Senior Device Quality Engineer III, Device Development Quality

Dennis Douroumis

University of Greenwich

Professor in Pharmaceutical Technology and Process Engineering, Director of Centre for Innovation in Process Engineering and Research (CIPER)

Dr Chris McConville

Sir Robert Aitken Institute for Medical Research University of Birmingham

Senior Lecturer in Pharmaceutics, Drug Formulation and Delivery

Dr Vivek Trivedi

University of Kent

Lecturer, Formulation Science Department of Pharmaceutical, Chemical and Environmental Sciences

Dr. HDR Denis Spitzer


Founding Director of the NS3E laboratory, Mixed Research Unit

Dr. Sharareh Salar-Behzadi

Research Center Pharmaceutical Engineering (RCPE)

Principal Scientist

Feng Zhang

University of Texas at Austin

Assistant Professor

Ferdinand Brandl

BASF SE, Nutrition and Health, Development Pharma Solutions

Head of Laboratory

Gregoire Schwach


Head Drug Delivery

Heinrich Haas

BioNTEch RNA Pharmaceuticals

Vice President RNA Formulation & Drug Delivery

James Humphrey


Applications Specialist

Jatin Patel

Constellation Pharmaceuticals

Executive Director-CMC

Jean Alié


Head of Section at Sanofi Solid State Characterization and 3D printing

Jean-René Authelin


Global Head of Pharmaceutical Engineering

Johannes Khinast

Graz University of Technology

Director Research Center Pharmaceutical Engineering

Jonas Fransson

Swedish Orphan Biovitrum AB

Director of Drug Product Development

Jonathan Armer



Kristin Lehmkemper


Senior Scientist

Mara van Haandel

DFE pharma

Innovation Manager

Mike Tate

Boehringer Ingelheim

Human Factors Manager

Mike Tobyn

Bristol-Myers Squibb

Research Fellow

Mostafa Nakach


Head of formulation and process development Biologics Drug Product Development

Muriel Didier


Head Human Factors

Nima Aghajari


Senior Simulation Engineer

Omar Naneh

Lek d d. (Novartis)

Senior scientist BPD DPD Operational Sciences

Otmane Boussif


Global Head Cell & Gene Therapy Technical Development

Paolo Avalle


Associate Principal Scientist

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Room 2 Chairperson

Pekka Kallunki


Principal Scientist

Philippe Lienard


Pre-Development Science Project Manager

Professor Ijeoma F. Uchegbu

UCL School of Pharmacy

Pro-Vice Provost - Africa and The Middle East Chair in Pharmaceutical Nanoscience

Professor Ijeoma Uchegbu

UCL School of Pharmacy

Chair in Pharmaceutical Nanoscience

Professor Khuloud Al-Jamal

King’s College London

Chair of Drug Delivery & Nanomedicine

Rene Holm


Head and Scientific Director, Liquids & Parenterals

Richard Green


Senior Director, Pharmaceutical Sciences

Rémy Kohler


Human Factors Engineer, Device and Packaging Development, PTDE-D

Satya Kishore Ravuri


Senior Group Leader, Early-Stage Pharmaceutical and Processing Development

Serge Mathonet


Global Regulatory Affairs Biologics Center CMC Interface

Shalini Andersson


Chief Scientist New Therapeutic Modalities

Sonoko Kanai


Associate Director

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling

Sven Stegemann

Graz University of Technology

Professor for Patient Centric Drug Development and Manufacturing

Thomas Schmidt


Principal Scientist

Thomas Kipping


Head of Drug Carriers

Torsten Kneuss


QA Manager Combination Products

Twinkle Christian


Process Development Scientist, Drug Product Technologies department

Werner Hoheisel


Group Lead Formulation Technologies

Yash Kapoor


Principal Scientist

Dr. Andreas Seidl


Chief Operating Officer

Dr. Andreas Sauer

SE Tylose GmbH & Co. KG

Technical Sales Director

Download 2019 Brochure